ARCHIVES

Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

Group Backing Epstein Received Grants From Reynolds Foundation

May 15, 1992

NIH advisors Review Intramural Program, Plan Spring Report

December 10, 1993

Columbia Formally Names As 21st Comprehensive Center

March 9, 1979

New CCOP RFA Available; Briefing At ASCO Jammed

June 2, 1989

Sen. Mack Seeks Research Funding For Shark Cartilage

July 29, 1994

Ovarian Cancer Screening Unnecessary for Most Women, Consensus Panel Says

April 15, 1994